Therefore, we leveraged the data from the UK Biobank, a large prospective cohort study, to systematically examine the associations between circulating liver function markers (ALT, AST, GGT, ALP, TBIL, ALB, and TP) and COPD risk. This evidence concerns the gene ALB and chronic obstructive pulmonary disease.